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Abstract
Background: Japanese encephalitis virus (JEV) is a member of the mosquito-borne Flaviviridae family of viruses
that causes human encephalitis. Upon infection of a new host, replication of viral RNA involves not only the viral
RNA-dependent RNA polymerase (RdRp), but also host proteins. Host factors involved in JEV replication are not
well characterized.
Results: We identified Hdj2, a heat-shock protein 40 (Hsp40)/DnaJ homolog, from a mouse brain cDNA library
interacting with JEV nonstructural protein 5 (NS5) encoding viral RdRp using yeast two-hybrid system. Specific
interaction of Hdj2 with NS5 was confirmed by coimmunoprecipitation and colocalization in JEV-infected cells.
Overexpression of Hdj2 in JEV-infected cells led to an increase of RNA synthesis, and the virus titer was elevated
approximately 4.5- to 10-fold. Knocking down of Hdj2 by siRNA reduced the virus production significantly.
Conclusions: We conclude that Hdj2 directly associates with JEV NS5 and facilitates viral replication. This study is
the first to demonstrate Hdj2 involved in JEV replication, providing insight into a potential therapeutic target and
cell-based vaccine development of JEV infection.
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Background
Japanese encephalitis virus (JEV), a mosquito-borne fla-
vivirus, is a leading cause of encephalitis in Eastern and
Southern Asia. The virus has a zoonotic transmission
cycle, with swine serving as the readily available amplify-
ing hosts for which infected mosquitoes transmit the
virus to humans. There are three very effective JEV
human vaccines that have been used and have reduced
the impact of JEV infection in Asian countries. These
are the Chinese-developed SA14-14-2 live-attenuated
vaccine, the conventional suckling mouse-brain derived,
formalin-inactivated vaccine, and the Vero cell derived,
formalin-inactivated vaccine [1,2]. However, with no
effective antiviral drugs available and high fatality rates
in humans, JE remains a worldwide public health pro-
blem [3,4]. The JEV genome is a single-strand positive
sense RNA, 10,976 nucleotides (nts) in length. The RNA
strand contains a type I cap at its 5’ end, and lacks a
poly A tail at its 3’ e n d .T h eg e n o m ee n c o d e sal a r g e
open reading frame (ORF) flanked by 5’ and 3’ untrans-
lated regions (UTRs). The single ORF is translated to a
polyprotein, which undergoes co- and post-translational
processing into three structural proteins (C, prM, and
E), and seven nonstructural proteins (NS1, NS2A, NS2B,
NS3, NS4A, NS4B, and NS5) [5].
The largest viral protein, NS5, is a multifunctional
protein. Although the structure and function of JEV
NS5 has not been thoroughly investigated, a comparison
of the deduced flavivirus amino acid sequences reveals
several homologous regions that indicate similar NS5
function among the flaviviruses [6]. The N-terminal part
of NS5 is a methyltransferase enzyme, and the NS5 C-
terminal exhibits RNA-dependent RNA polymerase
(RdRp) activity. The conserved GDD motif within the
RdRp domain plays a major role in RNA amplification
[7,8]. Although the replication of flaviviruses occurs in
the cytoplasm, a number of studies report that 20% of
the RdRp is resident within the nucleus [9,10]. The JEV
NS5 protein contains a nuclear localization signal (NLS)
responsible for protein translocation into the nucleus.
Although the purpose of nuclear localization for viral
protein remains unknown, it may facilitate viral
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infection. In addition to viral replication, NS5 may also
play a role in pathogenesis [11]. Recent advances in our
understanding of many functional roles, and the elucida-
tion of the NS5 structure of other flaviviruses such as
Dengue virus and West Nile virus, has made NS5 an
important target for antiflaviviral drug development
[6,12].
Numerous studies have demonstrated that host factors
participate in RNA viral replication. These host factors
enhance viral RNA replication, RNA stability, genome
translation, posttranslational modification, formation of
the replication complex, and viral assembly [13]. To
obtain more information regarding the interactions
between host factors and the NS5 protein, we performed
a yeast-two hybrid assay using a mouse-brain cDNA
library. We identified several host factors, and further
characterized Hdj2, a heat-shock protein 40 (Hsp40)/
DnaJ homolog. Heat-shock proteins (Hsps) are cellular
chaperons that normally facilitate cellular protein trans-
lation, folding, trafficking, and degradation [14]. Hsp40
is often referred to as a co-chaperon; it associates with
Hsp70 and influences chaperon function [15,16]
In this study, we confirmed the interaction of Hdj2
with NS5 by coimmunoprecipitation (Co-IP), Western
blotting, and immunofluorescence assay. Results from
overexpression and silencing of the expression of Hdj2
protein in JEV-infected cells,i n d i c a t et h a th o s tH d j 2
associates with JEV NS5 and facilitates viral replication.
Results
JEV NS5 protein interacts with Hdj2 in vivo
Hdj2 is among the candidates that interact with NS5 by
yeast two-hybrid assay (described in Materials and
Methods); thus, specificity of the interaction requires
verification to avoid a false positive result. To this end,
cell lysates from mock- and JEV-infected cells were har-
vested and subjected to immunoprecipitation with anti-
Hdj2 antibody. The immunoprecipitates were character-
ized by Western blot analysis using anti-NS5 specific
antibody. Figure 1A shows coimmunoprecipitation of
NS5 with anti-Hdj2 antibody in JEV-infected cells (Fig-
ure 1A, lanes 6 and 7), but not in the mock-infected
cells (Figure 1A, lane 5), indicating a specific interaction
between host Hdj2 and the viral NS5 protein. By con-
trast, no NS5 was detected when coimmunoprecipitation
without any antibody added to the JEV-infected lysates
(Figure 1A, lane 8) or negative control [17]. These
observations indicate that Hdj2 interacts with NS5 in
JEV-infected cells.
Colocalization of Hdj2 and NS5 in JEV-infected cells
To investigate the intracellular distribution of the NS5
and Hdj2 upon JEV infection, we examined the
localization of these proteins using confocal microscopy
of the mock- and JEV-infected cells. Dual-labeled immu-
nofluorescence staining was conducted using rabbit anti-
NS5 serum and mouse anti-Hdj2 serum as primary anti-
bodies in combination with FITC-conjugated anti-rabbit
and Cy3-conjugated anti-mouse secondary antibodies.
The expression of viral NS5 protein was detected predo-
minantly in the cytoplasm of infected cells (Figure 1B,
panel IV), but not in the mock-infected cells (Figure 1B,
panel I). The constitutive expression of Hdj2 was
detected in both mock-infected and infected cells (Fig-
ure 1B, panels II & V). Upon JEV infection, the images
of dual-labeled immunofluorescence showed yellow col-
oration (Figure 1B, panel VI), indicating that NS5 and
NS5
M. Inf. M. M. Inf. Inf. Inf. Inf.
Anti-NS5 No Ab. 
Without
IP
234 5 67 8 1
130
95
72
1
Anti-Hdj2
CO-IP
36 hpi
Mock
NS5 Hdj2 Merge
A B C
DEF
I II III
IV V VI
A
B
Figure 1 JEV viral NS5 interacts with Hdj2 in vivo.A .H E K 2 9 3
cells were mock-infected or infected with JEV and harvested at 48 h
post-infection. Cell lysates were subjected to co-
immunoprecipitation (IP) with antibodies against NS5 or anti-Hdj2,
followed by Western blot analysis for the detection of NS5. Lanes 1
and 2, Mock- and JEV-infected cell lysates; lanes 3 and 4, Co-IP with
anti-NS5 antibody; lanes 5-7, Co-IP with anti-Hdj2 antibody (0.5 μg
and 1 μg of anti-Hdj2 antibody was used for lanes 6 and 7,
respectively); lane 8, Co-IP with no added antibody. B. Mock- or JEV-
infected HEK293 cells were stained by indirect immunofluorescence
using rabbit anti-NS5 polyclonal antibodies (panel I, IV), and mouse
anti-Hdj2 antibody (panel II, V) and detected by FITC-conjugated
goat anti-rabbit and CY3-donkey anti-mouse antibody, respectively.
Panels III and VI are merged images from two previous panels. The
enlarged image of the selected area marked by an arrow is given in
the upper right corner of panel VI. Cells were viewed at 1000 ×
magnification; a 20 μm scale bar is shown.
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infected cells.
Overexpression of recombinant Hdj2 protein facilitates
JEV replication
To test whether Hdj2 facilitates JEV replication, the
Hdj2 gene was cloned into p3XFLAG-Myc-CMV-26
expression vector (see Materials and Methods) and
transfected into HEK293T cells. High expression levels
of Flag-tag Hdj2 were observed as early as at 12 h post-
transfection (Figure 2A, lane 2), and were maintained to
72 h post-transfection (Figure 2A, lanes 3-6). Thus,
infection of JEV was performed at 12 h post-transfection
of the overexpressed Flag-tag Hdj2, followed by total
RNA extraction at 12, 24, 36, and 48 h post-infection
for the detection of viral RNA. The results showed that
JEV RNA synthesis increased 2- to 4-fold in the Hdj2
transfected cells, compared to mock-transfected cells
(Figure 2B &2C). Supernatant containing newly released
virus particles was collected at the same time points as
indicated above to determine the virus titer. The titer
increased 4.5- to 10-fold in the Hdj2 transfected cells,
compared to mock-transfected cells (Figure 2D &2E).
The virus titer also increased in cells transfected with
Hdj2 as a fusion protein with green fluorescence protein
(pEGFP-Hdj2), but not in the pEGFP-transfected, or
mock-transfected cells (Figure 2F). Overall, these results
indicate that overexpression of Hdj2 protein facilitates
JEV replication.
Silencing Hdj2 impairs JEV replication
To further investigate the role of Hdj2 in JEV replica-
tion, we treated HEK293 cells with Hdj2 siRNA and
negative control siRNA prior to JEV infection. Western
blot analysis showed that Hdj2 levels in the knockdown
cells were reduced to approximately 40% of those
observed in control cells (Figure 3A). The cells were
then infected with JEV. At 24 h post-infection, the NS5
expression level was reduced by approximately 50% in
Hdj2-silenced cells in comparison with the untreated or
scrambled siRNA treated cells (Figure 3B). Furthermore,
Hdj2-silenced cells also reduced the virus titer (data not
shown). This result supports the hypothesis that Hdj2 is
essential for JEV replication.
Discussion
Dissecting the host factors involved in viral replication
helps understand the molecular mechanism of viral
pathogenesis. In this study, we show for the first time
that JEV NS5 interacts with one member of the heat-
shock protein family, Hdj2, which we identified by
yeast two-hybrid screening, and further confirmed by
immunoprecipitation and colocalization studies (Figure
1).
Cellular heat-shock proteins are chaperon molecules,
known to participate in a variety of cellular processes
such as protein folding, protein translocation, and pro-
tein degradation [18]. Hdj2 belongs to the type I DnaJ
(Hsp40) family [19]. Hsp40 binds to unfolded proteins,
interacts with Hsp70 as a cochaperon, and stimulates
ATP hydrolysis [20]. The type I DnaJ family is defined
by the presence of an N-terminal J domain, followed by
a glycine and phenylalanine-rich domain, a cysteine-rich
C
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Figure 2 Overexpression of Hdj2 facilitates virus replication.A .
HEK293T cells were mock-transfected or transfected with Flag-Hdj2
expressing plasmid. The cells were harvested at the indicated hour
post-transfection (hpt), and subjected to Western blotting analysis
using anti-Flag antibody for detection of Flag-Hdj2 expression. B.
Transfected cells were infected with JEV. The total RNA and
supernatant were harvested from mock or Hdj2-transfected at the
indicated hour post-infection (hpi) and subjected to Northern
analysis, or virus titer determination, respectively. The RNA was
probed with a DIG-labeled oligonucleotide detecting nt 10950 to nt
10976 in the 3’ UTR and an oligonucleotide probe detecting 18S
rRNA. C. The amounts of RNA genome were normalized to that
present in the 18S rRNA, and the relative amounts were plotted. D
and E. The virus titers from each time point were calculated and
plotted. F. JE virus titer was measured at 48 h post-infection of
pEGFP-Hdj2, pEGFP, or mock-transfected cells. Error bars indicate the
standard deviations of results from three independent experiments.
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conserved histidine-proline-aspartic acid tripeptide motif
(HPD motif) in the J domain is critical for accelerating
Hsp70 ATPase activity [21,22]. Additionally, Hdj2 is a
multifunction protein that includes (i) facilitating andro-
gen receptors bound to androgen through the zinc fin-
ger domain [23]; (ii) regulation of mitochondrial protein
import [24,25]; and (iii) cooperation with Hsp70 to sup-
press protein aggregation and apoptosis [26,27].
Although Hsp70 involvement at different stages of the
viral life cycle, including entry, replication, gene expres-
sion, and encapsidation has been extensively studied,
there are relatively few reports of Hsp40 involvement in
the viral life cycle [15]. Hsp40 may ensure the correct
conformation of the viral replication complex, or may
interact with viral proteins, and often facilitates viral
replication [28,29]. Hsp40 (Ydj1P) participated in viral
RdRp folding in Brome mosaic virus-infected cells, and
facilitated viral negative-strand RNA synthesis [30].
DnaJ homologs play a role in suppressing virus-induced
apoptosis [31], and furthermore, DnaJ homologs sup-
press antiviral processes by regulating the activities of
other cellular proteins. In Influenza virus-infected cells,
P58
IPK (DnaJ homolog) phosphorylation of PKR was
inhibited, blocking the antiviral pathway [32].
Flavivirus infection involves the synthesis of large
numbers of viral proteins, which induce ER stress, caus-
ing an unfolded protein response in infected cells,
leading to cell apoptosis [33,34]. JEV NS5 proteins, as
with other flaviviruses, were shown to be interferon
(IFN) antagonists [35,36]. NS5 blocks the IFN-stimu-
lated JAK/Stat pathway, and evades IFN-induced
responses. Since NS5 interacts with Hdj2, it is intriguing
to know whether this interaction helps NS5 interfere
with IFN or other antiviral mechanisms. Although it is
not known at what stage Hsp40 plays a role in JEV
infection, our data clearly indicate that overexpression
of Hdj2 enhances viral gene expression and viral pro-
duction (Figure 2), and that the inhibition of Hdj2
expression reduces viral gene expression (Figure 3).
These results suggest that JEV recruits the host heat-
shock proteins to facilitate its replication. We postulate
that mechanism(s) to enhance viral replication could (i)
facilitate viral RNA replication, (ii) suppress apoptosis of
the host cells, (iii) block host cell antiviral mechanisms,
or (iv) may operate by other unidentified mechanisms.
Natural hosts of JEV include mosquitoes, humans,
waterfowls, and pigs. The body temperatures of these
species range from room temperature to greater than
40°C. It is therefore likely that the virus recruits a host
heat-shock protein to maintain proper conformation of
the RdRp for the replication of viral genome at different
temperatures. Hsp70 has been reported as a possible
receptor for JEV infection [37,38]. Whether the interac-
tion between Hsp40 and Hsp70 either directly or indir-
ectly plays a role in virus production remains to be
determined. Recently, Yi et al. reported that overexpres-
sion of DNAJC14, a member of Hsp40 chaperone pro-
teins, inhibited the viral replication of various
Flaviviridae family members [39]. However, silencing
DNAJC14 also inhibited replication of the yellow fever
virus, indicating that the host Hsp40 chaperone may be
involved in more than one stage of the flavivirus life
cycle.
Vaccination is the most effective method of preventing
JE infection in humans. The currently used vaccine
includes a mouse brain-derived, formalin-inactivated
JEV or a new inactivated, Vero cell culture-derived JE
vaccine [40]. It has been showed that there is a signifi-
cant risk in using the inactivated mouse brain-derived
vaccine, particularly regarding neurological and allergic
reactions [41]. Thus, the cell culture-based vaccine is a
better alternative than the mouse-brain derived vaccine.
Because of the high cost of tissue culture, our finding
that overexpression of Hdj2 significantly increases the
viral titer, could serve as a basis for further improve-
ments of cell culture-based vaccine.
Conclusions
This is the first report of host heat-shock protein being
directly associated with NS5, and facilitating virus repli-
cation. Identification of the interacting domains in NS5
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Figure 3 Silencing Hdj2 using siRNA decreases JEV NS5
production. HEK293 cells were transfected with siRNA against Hdj2,
or scrambled siRNA (negative control, see the description in the
Materials and Methods). A. The down-regulation of Hdj2 was
determined by Western blot analysis using antibodies specific to
Hdj2. The transfected cells were then infected with JEV. The cell
lysates were collected at 24 h post-infection and subjected to
western blot analysis using anti-Hdj2, anti-NS5, and anti b-actin
specific antibodies. B. Quantitative measurement of the indicated
band intensities of Hdj2 and NS5 from JEV-infected scrambled siRNA
treated cells, or cells treated with siRNA against Hdj2. Results were
derived from three independent experiments.
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protein interactions. Knowledge of the structures of
these interacting domains would be useful for antiviral
drug design and for the improving virus yield in the tis-
sue culture-based live attenuated or inactivated vaccine.
Materials and methods
Cells and viruses
We used the JEV RP-9 strain in this study [42]. Baby
hamster kidney (BHK-21) cells were used for JEV propa-
gation and plaque assay. BHK-21 cells were grown in
RPMI-1640 medium (Invitrogen) supplemented with 2%
fetal bovine serum (FBS) (Invitrogen) at 37°C. Human
embryonic kidney (HEK293 and HEK293T) cells were
grown in DMEM medium (Invitrogen) containing 10%
FBS.
Yeast two-hybrid screening
The bait plasmid, pGBKT7-NS5, was constructed by
cloning the PCR amplified, full-length JEV NS5 gene,
into the BamHI site of pGBKT7 (Clontech) in frame
with the GAL4 DNA binding domain and transformed
into Saccharomyces cerevisiae strain Y190. A Match-
maker pretransformed mouse brain cDNA library (Clon-
tech) was screened via yeast mating by incubating 1 ml
of the pretransformed library (5 × 10
6 CFU) with the
bait-transformed Y190 strain, according to the manufac-
turer’s directions. The entire mating culture was plated
onto -His/-Leu/-Trp synthetic defined medium contain-
ing 25 mM 3-amino 1, 2,4-triazole (3-AT) and incu-
bated at 30°C for 3 to 7 days. Colonies were picked,
restreaked onto fresh selective medium, and were sub-
jected to a LacZ colony-lift filter assay. Plasmid DNA
was isolated from clones positive for b-galactosidase
activity. Sequence analysis revealed that one of the selec-
tive positive clones is DnaJ homolog.
Construction of plasmid
The p3XFLAG-Hdj2 plasmid was constructed by clon-
ing the 1191-bp fragment, amplified from HEK293 cell
cDNA, with Hdj2(+)1BglII (5’-gaagatctgATGGTGAAA-
GAAACAACTTA-3’) and Hdj2(-)1191XbaI (5’-
gctctgagGGTCTGACACTGAACA-3’)p r i m e r s ,i n t o
p3XFLAG-Myc-CMV-26 expression vector (Sigma-
Aldrich). The Hdj2 gene was also subcloned into
pEGFP-C1 (Clontech) to form pEGFP-Hdj2. Sequences
of the construct were confirmed by sequencing.
Transfection and Northern blot analysis
Transfection was performed using Lipofectamine 2000
in OptiMEM according to the manufacturer’sp r o t o c o l
(Invitrogen). Briefly, HEK293T cells in 60-mm plates at
50 to 60% confluence were transfected with 4 μgo f
p3XFLAG-Hdj2 (or pEGFP-Hdj2) plasmid DNA or
mock transfected with H2Oo rv e c t o ra l o n e .A t1 2h
post-transfection, cells were infected with JEV at a mul-
tiplicity of infection (MOI) of one, by incubating cells
with inoculum at 37°C for 1 h, and refeeding with a
growth medium until cytoplasmic RNA extraction was
performed at 12, 24, 36, and 48 h post-infection. The
supernatant was collected at the same time point as
shown above, and titrated for infectious virus, as
described [43]. Total RNA was extracted with REzolTM
C&T reagent (Protech), and Northern analyses were
conducted, as described [44].
Coimmunoprecipitation assay
HEK293 cells (approximately 1 × 10
7 cells) were unin-
fected or infected with JEV RP9 at an MOI value of 0.1.
At 48 h post-infection, cells were harvested, immuno-
precipitated, and Western blotted as described elsewhere
[17]. Briefly, cell lysates were incubated on ice for 10
min, and cell debris was removed by centrifugation. One
milligram of whole cell extract per reaction was pre-
cleaned with 20 μl protein G-plus agarose beads (Santa
Cruz) at 4°C for 1 h with rotation. The clarified super-
natants were incubated with anti-NS5 polyclonal anti-
serum prepared in rabbits [45] or mouse anti-Hdj2
monoclonal antibody (USBiological) at 4°C overnight.
Prewashed protein G-plus agarose beads were added to
the mixture, and incubated at 4°C for 1 h, and the
immune complexes were washed four times with RIPA
buffer. The final precipitate was boiled in a protein load-
ing buffer for 5 min and eluted on SDS-10% PAGE for
Western blot analysis.
Immunofluorescence staining assay
HEK293T cells were seeded on coverslips (15 mm dia-
meter) on 24-well tissue culture plates and incubated
overnight. Cells were infected with JEV at an MOI of
0.1. At 36 h post-infection, cells were washed three
times with cold phosphate-buffered saline (PBS), fol-
lowed by fixation with ice-cold methanol. After washing
with PBS and blocking with skimmed milk, samples
were incubated with the rabbit anti-NS5 polyclonal anti-
body and mouse anti-Hdj2 monoclonal antibody (Jack-
son) for 1 h at 37°C. After five washes with PBS, the
cells were incubated with FITC-conjugated goat anti-
rabbit and CY3-conjugated donkey anti-mouse second-
ary antibodies (Jackson). After a further five washes with
PBS, the coverslips were mounted and examined by
confocal laser scanning microscopy (Leica TCS SL).
siRNA transfection assay
Hdj2 siRNA (5’-CGUCAUCACCUCUCAUCCA-3’)w a s
designed and synthesized by Sigma Aldrich. Scrambled
siRNA (medium GC of StealthTM RNAi) was used as a
negative control (Invitrogen). The siRNA transfection
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gen) according to manufacturer’s instruction. Briefly, 10
μl of Lipofectamine RNAiMAX and 180 μl of siRNA (at
a final concentration 30 nM) were mixed with 1 ml
OptiMEM (Invitrogen), followed by incubation for 20
min at room temperature. The mixture was then added
with 5 ml cell growth medium and transfected into
HEK293 cells for 2 days. The transfected cells were
i n f e c t e dw i t hJ E Va ta nM O Iv a l u eo f1 .A t2 4hp o s t -
infection, the supernatant was collected for quantitation
of the virus titer, and the cell lysates were harvested for
Western blot analysis using anti-Hdj2 (USBiological),
anti-NS5, or anti-b-actin (Sigma) antibodies. Quantifica-
tion of the intensity of bands on the Western blot has
been done using the ImageJ gel analysis as described at
http://lukemiller.org/index.php/2010/11/analyzing-gels-
and-western-blots-with-image-j/.
List of abbreviations
DnaJ: J-domain-containing cochaperon initially identified in E. coli; Hdj2: type
I Hsp40; Hsp: heat shock protein; JEV: Japanese encephalitis virus; MOI:
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RNA polymerase.
Acknowledgements
We thank Dr. Scott C. Schuyler for critically reading the manuscript, and Dr.
Kao-Jean Huang for many helpful discussions. This work was supported by
grants from the National Science Council in Taiwan: NSC 99-2321-B-002-025
to RW and NSC 98-2320-B-259-002-MY3 to RYC.
Author details
1Department of Biomedical Sciences, Chang Gung University; Tao Yuan
33302, Taiwan, ROC.
2Research Center for Emerging Viral Infections, Chang
Gung University, Tao Yuan 33302, Taiwan, ROC.
3Institute of Biotechnology
and Department of Life Science, National Dong Hwa University, Hualien
97401, Taiwan, ROC.
Authors’ contributions
RYW and YRH participated in the design of RNAi experiment and helped to
draft the manuscript. YRH confirmed the interaction. KMC and ZLK carried
out the overexpression experiments. CYH performed the knockdown
experiments. RYC conceived of the study, participated in its design and
coordination, and finalized the manuscript in its final form. All authors read
and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 August 2011 Accepted: 14 October 2011
Published: 14 October 2011
References
1. Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B,
Tungtaeng A, Gettayacamin M, Dewasthaly S: Correlation of protection
against Japanese encephalitis virus and JE vaccine (IXIARO((R))) induced
neutralizing antibody titers. Vaccine 2011, 29:5925-5931.
2. Fischer M, Lindsey N, Staples JE, Hills S: Japanese encephalitis vaccines:
recommendations of the Advisory Committee on Immunization
Practices (ACIP). MMWR Recomm Rep 2010, 59:1-27.
3. van den Hurk AF, Ritchie SA, Mackenzie JS: Ecology and geographical
expansion of Japanese encephalitis virus. Annu Rev Entomol 2009,
54:17-35.
4. Ghosh D, Basu A: Japanese encephalitis-a pathological and clinical
perspective. PLoS Negl Trop Dis 2009, 3:e437.
5. Lindenbach BD, Thiel HJ, Rice CM: Flaviviridae: The Viruses and Their
Replication. In Fields Virology. Volume 1.. 5 edition. Edited by: Knipe DM,
Howley PM. Philadephia, PA.: Lippincott William 2007:1101-1152.
6. Davidson AD: Chapter 2. New insights into flavivirus nonstructural
protein 5. Adv Virus Res 2009, 74:41-101.
7. Kim YG, Yoo JS, Kim JH, Kim CM, Oh JW: Biochemical characterization of a
recombinant Japanese encephalitis virus RNA-dependent RNA
polymerase. BMC Mol Biol 2007, 8:59.
8. Yu F, Hasebe F, Inoue S, Mathenge EG, Morita K: Identification and
characterization of RNA-dependent RNA polymerase activity in
recombinant Japanese encephalitis virus NS5 protein. Arch Virol 2007,
152:1859-1869.
9. Uchil PD, Kumar AV, Satchidanandam V: Nuclear localization of flavivirus
RNA synthesis in infected cells. J Virol 2006, 80:5451-5464.
10. Edward Z, Takegami T: Localization and functions of Japanese
encephalitis virus nonstructural proteins NS3 and NS5 for viral RNA
synthesis in the infected cells. Microbiol Immunol 1993, 37:239-243.
11. Lin RJ, Liao CL, Lin E, Lin YL: Blocking of the alpha interferon-induced Jak-
Stat signaling pathway by Japanese encephalitis virus infection. J Virol
2004, 78:9285-9294.
12. Qing M, Yang F, Zhang B, Zou G, Robida JM, Yuan Z, Tang H, Shi PY:
Cyclosporine inhibits flavivirus replication through blocking the
interaction between host cyclophilins and viral NS5 protein. Antimicrob
Agents Chemother 2009, 53:3226-3235.
13. Ahlquist P, Noueiry AO, Lee WM, Kushner DB, Dye BT: Host factors in
positive-strand RNA virus genome replication. J Virol 2003, 77:8181-8186.
14. Young JC, Agashe VR, Siegers K, Hartl FU: Pathways of chaperone-
mediated protein folding in the cytosol. Nat Rev Mol Cell Biol 2004,
5:781-791.
15. Knox C, Luke GA, Blatch GL, Pesce ER: Heat shock protein 40 (Hsp40)
plays a key role in the virus life cycle. Virus Res 2011, 160:15-24.
16. Qiu XB, Shao YM, Miao S, Wang L: The diversity of the DnaJ/Hsp40 family,
the crucial partners for Hsp70 chaperones. Cell Mol Life Sci 2006,
63:2560-2570.
17. Yang SH, Liu ML, Tien CF, Chou SJ, Chang RY: Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) interaction with 3’ ends of
Japanese encephalitis virus RNA and colocalization with the viral NS5
protein. J Biomed Sci 2009, 16:40.
18. Cheetham ME, Caplan AJ: Structure, function and evolution of DnaJ:
conservation and adaptation of chaperone function. Cell Stress
Chaperones 1998, 3:28-36.
19. Vos MJ, Hageman J, Carra S, Kampinga HH: Structural and functional
diversities between members of the human HSPB, HSPH, HSPA, and
DNAJ chaperone families. Biochemistry 2008, 47:7001-7011.
20. Walter S, Buchner J: Molecular chaperones–cellular machines for protein
folding. Angew Chem Int Ed Engl 2002, 41:1098-1113.
21. Kampinga HH, Craig EA: The HSP70 chaperone machinery: J proteins as
drivers of functional specificity. Nat Rev Mol Cell Biol 2010, 11:579-592.
22. Jiang J, Maes EG, Taylor AB, Wang L, Hinck AP, Lafer EM, Sousa R: Structural
basis of J cochaperone binding and regulation of Hsp70. Mol Cell 2007,
28:422-433.
23. Fliss AE, Rao J, Melville MW, Cheetham ME, Caplan AJ: Domain
requirements of DnaJ-like (Hsp40) molecular chaperones in the
activation of a steroid hormone receptor. J Biol Chem 1999,
274:34045-34052.
24. Bhangoo MK, Tzankov S, Fan AC, Dejgaard K, Thomas DY, Young JC:
Multiple 40-kDa heat-shock protein chaperones function in Tom70-
dependent mitochondrial import. Mol Biol Cell 2007, 18:3414-3428.
25. Terada K, Kanazawa M, Bukau B, Mori M: The human DnaJ homologue dj2
facilitates mitochondrial protein import and luciferase refolding. J Cell
Biol 1997, 139:1089-1095.
26. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, Zoghbi HY:
Chaperone suppression of aggregation and altered subcellular
proteasome localization imply protein misfolding in SCA1. Nat Genet
1998, 19:148-154.
27. Wyttenbach A, Carmichael J, Swartz J, Furlong RA, Narain Y, Rankin J,
Rubinsztein DC: Effects of heat shock, heat shock protein 40 (HDJ-2), and
proteasome inhibition on protein aggregation in cellular models of
Huntington’s disease. Proc Natl Acad Sci USA 2000, 97:2898-2903.
28. Weeks SA, Miller DJ: The heat shock protein 70 cochaperone YDJ1 is
required for efficient membrane-specific flock house virus RNA
Wang et al. Virology Journal 2011, 8:471
http://www.virologyj.com/content/8/1/471
Page 6 of 7replication complex assembly and function in Saccharomyces cerevisiae.
J Virol 2008, 82:2004-2012.
29. Kumar M, Mitra D: Heat shock protein 40 is necessary for human
immunodeficiency virus-1 Nef-mediated enhancement of viral gene
expression and replication. J Biol Chem 2005, 280:40041-40050.
30. Tomita Y, Mizuno T, Diez J, Naito S, Ahlquist P, Ishikawa M: Mutation of
host DnaJ homolog inhibits brome mosaic virus negative-strand RNA
synthesis. J Virol 2003, 77:2990-2997.
31. Gotoh T, Terada K, Oyadomari S, Mori M: hsp70-DnaJ chaperone pair
prevents nitric oxide- and CHOP-induced apoptosis by inhibiting
translocation of Bax to mitochondria. Cell Death Differ 2004, 11:390-402.
32. Sharma K, Tripathi S, Ranjan P, Kumar P, Garten R, Deyde V, Katz JM, Cox NJ,
Lal RB, Sambhara S, Lal SK: Influenza A Virus Nucleoprotein Exploits
Hsp40 to Inhibit PKR Activation. PLoS One 2011, 6:e20215.
33. Medigeshi GR, Lancaster AM, Hirsch AJ, Briese T, Lipkin WI, Defilippis V,
Fruh K, Mason PW, Nikolich-Zugich J, Nelson JA: West Nile virus infection
activates the unfolded protein response, leading to CHOP induction and
apoptosis. J Virol 2007, 81:10849-10860.
34. Su HL, Liao CL, Lin YL: Japanese encephalitis virus infection initiates
endoplasmic reticulum stress and an unfolded protein response. J Virol
2002, 76:4162-4171.
35. Werme K, Wigerius M, Johansson M: Tick-borne encephalitis virus NS5
associates with membrane protein scribble and impairs interferon-
stimulated JAK-STAT signalling. Cell Microbiol 2008, 10:696-712.
36. Lin RJ, Chang BL, Yu HP, Liao CL, Lin YL: Blocking of interferon-induced
Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein
tyrosine phosphatase-mediated mechanism. J Virol 2006, 80:5908-5918.
37. Das S, Laxminarayana SV, Chandra N, Ravi V, Desai A: Heat shock protein
70 on Neuro2a cells is a putative receptor for Japanese encephalitis
virus. Virology 2009, 385:47-57.
38. Ren J, Ding T, Zhang W, Song J, Ma W: Does Japanese encephalitis virus
share the same cellular receptor with other mosquito-borne flaviviruses
on the C6/36 mosquito cells? Virol J 2007, 4:83.
39. Yi Z, Sperzel L, Nurnberger C, Bredenbeek PJ, Lubick KJ, Best SM,
Stoyanov CT, Law LM, Yuan Z, Rice CM, MacDonald MR: Identification and
characterization of the host protein DNAJC14 as a broadly active
flavivirus replication modulator. PLoS Pathog 2011, 7:e1001255.
40. Wilder-Smith A, Halstead SB: Japanese encephalitis: update on vaccines
and vaccine recommendations. Curr Opin Infect Dis 2010, 23:426-431.
41. Takahashi H, Pool V, Tsai TF, Chen RT: Adverse events after Japanese
encephalitis vaccination: review of post-marketing surveillance data
from Japan and the United States. The VAERS Working Group. Vaccine
2000, 18:2963-2969.
42. Chen LK, Lin YL, Liao CL, Lin CG, Huang YL, Yeh CT, Lai SC, Jan JT, Chin C:
Generation and characterization of organ-tropism mutants of Japanese
encephalitis virus in vivo and in vitro. Virology 1996, 223:79-88.
43. Tsai KN, Tsang SF, Huang CH, Chang RY: Defective interfering RNAs of
Japanese encephalitis virus found in mosquito cells and correlation with
persistent infection. Virus Res 2007, 124:139-150.
44. Lin KC, Chang HL, Chang RY: Accumulation of a 3’-terminal genome
fragment in Japanese encephalitis virus-infected mammalian and
mosquito cells. J Virol 2004, 78:5133-5138.
45. Lee HJ: Expression of RNA-dependent RNA polymerase of Japanese
encephalitis virus and preparation of of polyclonal antibody. Master
thesis National Dong Hwa University, Institute of Biotechnology and
Department of Life Science; 2002.
doi:10.1186/1743-422X-8-471
Cite this article as: Wang et al.: DnaJ homolog Hdj2 Facilitates Japanese
Encephalitis Virus Replication. Virology Journal 2011 8:471.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Wang et al. Virology Journal 2011, 8:471
http://www.virologyj.com/content/8/1/471
Page 7 of 7